A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis with the use of prescribed testosterone. However, Mount Sinai researchers have found that testosterone treatment may be safer than previously reported, with results published recently in The Journal of Clinical Endocrinology & Metabolism. Mount...
As we highlight the Endocrine Society’s Special Interest Groups, we talk to Michelle Cordoba Kissee, MD, from the Transgender Research and Medicine SIG, who discusses the prevalence of obesity in this patient population. In 2019, the Endocrine Society launched its Special Interest Groups (SIGs) so members with a similar interest could come together and collaborate...
The Endocrine Society applauded the Court of Appeal’s ruling that transgender and gender diverse teenagers are competent to give consent to treatment to delay puberty. The decision overturns the court’s December 2020 ruling in Bell v Tavistock and Portman NHS Health Foundation. The ruling preserves access to medical treatment for transgender and gender diverse teenagers and protects the ability...
Transgender Teenagers Deserve Same Access to Medical Care as Other Youth
Endocrine Society, coalition file intervention in UK High Court appeal The Endocrine Society and a coalition of LGBTQ+ youth and reproductive health organizations argued in a joint submission to the High Court of England and Wales that transgender teenagers should be able to give informed consent to treatment the same way teenagers with other medical conditions can. The coalition submitted a written intervention as part of the appeal of Bell v Tavistock and Portman NHS Health Foundation, a case where...
Endocrine Society Applauds AMA Resolution Supporting Access to Gender-affirming Care
The Endocrine Society praised the American Medical Association’s House of Delegates for passing a resolution opposing efforts to criminalize medical care for transgender youth. The resolution, which cites the Endocrine Society’s Clinical Practice Guidelines on transgender care, makes it AMA policy to oppose the criminalization and otherwise undue restriction of evidence-based gender-affirming care. The Endocrine...
As with most surgeries, venous thromboembolism is always a potential risk and transgender surgical procedures are no different. A new study published in The Journal of Clinical Endocrinology & Metabolism shows no increased clot risk while maintaining hormone therapy during gender affirming surgery. Transgender medicine continues to grow and evolve – more and more people...
Endocrine Society Condemns Efforts to Block Access to Medical Care for Transgender Youth
Medical evidence, not politics, should inform treatment decisions The Endocrine Society opposes legislative efforts that do not conform to medical evidence and clinical practice to prevent transgender and gender diverse adolescents from accessing gender-affirming medical care. Arkansas passed a law April 6 prohibiting gender-affirming care for minors, the first law of its kind in the U.S. Seventeen other states...
ENDO 2021 Preview: Lifetime Care: A Comprehensive Look at Treating Transgender Patients
A relatively new field, transgender medicine will be featured in the ENDO 2021 session, “Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition,” a live, 90-minute program taking place Sunday, March 21, 2021, at 12:15 p.m. Program co-chair, Stephen M. Rosenthal, MD, and Sabine Hannema, MD, PhD, talk to Endocrine News about what attendees can...
